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Abstract
The rapid mutation of human immunodeficiency virus-type 1 (HIV-1) and the limited characterization of the composition
and incidence of the variant population are major obstacles to the development of an effective HIV-1 vaccine. This issue was
addressed by a comprehensive analysis of over 58,000 clade B HIV-1 protein sequences reported over at least 26 years. The
sequences were aligned and the 2,874 overlapping nonamer amino acid positions of the viral proteome, each a possible
core binding domain for human leukocyte antigen molecules and T-cell receptors, were quantitatively analyzed for four
patterns of sequence motifs: (1) ‘‘index’’, the most prevalent sequence; (2) ‘‘major’’ variant, the most common variant
sequence; (3) ‘‘minor’’ variants, multiple different sequences, each with an incidence less than that of the major variant; and
(4) ‘‘unique’’ variants, each observed only once in the alignment. The collective incidence of the major, minor, and unique
variants at each nonamer position represented the total variant population for the position. Positions with more than 50%
total variants contained correspondingly reduced incidences of index and major variant sequences and increased minor and
unique variants. Highly diverse positions, with 80 to 98% variant nonamer sequences, were present in each protein,
including 5% of Gag, and 27% of Env and Nef, each. The multitude of different variant nonamer sequences (i.e. nonatypes;
up to 68%) at the highly diverse positions, represented by the major, multiple minor, and multiple unique variants likely
supported variants function both in immune escape and as altered peptide ligands with deleterious T-cell responses. The
patterns of mutational change were consistent with the sequences of individual HXB2 and C1P viruses and can be
considered applicable to all HIV-1 viruses. This characterization of HIV-1 protein mutation provides a foundation for the
design of peptide-based vaccines and therapeutics.
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Introduction
The quasispecies replication of RNA viruses has been recog-
nized for over 30 years following the initial observation of the high
proportion of mutants in a growing population of bacteriophage
Qb [1]. HIV-1 is now a classic example of this model of rapid
genome evolution [2–6]. As a result of high rates of genetic
mutation [7] and recombination [8], cell infection by HIV-1 is
followed by immune escape of viruses with related and highly
diverse genotypes [9,10]. Even a single founder virus, when
introduced into cells, is quickly transformed into a quasispecies
assortment of progeny viruses [11–13]. Given the vast array of
different genotypes generated in every replication cycle, the
challenge of designing a vaccine that would prevent the immune
escape of the mutant progeny of infected cells is widely recognized
[14–17]. A continuing goal is a greater understanding of HIV-1
diversity and an effective strategy to overcome this diversity.
Towards this end, there is a need for more detailed and
quantitative analysis of the extent of HIV-1 mutational changes,
including the composition and incidence of the different variants
of the viral proteome.
Herein, we describe a large-scale analysis of the diversity of
HIV-1 sequences reported over at least 26 years. Clade B was
selected for the developmental studies as it had the largest number
of recorded HIV-1 sequences. Over 58,000 clade B sequences,
both partial- and full-length and distributed among the nine
proteins, were aligned, with over 1,000 sequences at most
nonamer positions (Table S1). As the immune-relevance of the
sequences was a primary focus of the study, the analysis was
conducted with 2,874 nonamer positions, overlapping eight
residues (1–9, 2–10, etc.), where each nonamer at the positions is
a potential viral human leukocyte antigen (HLA) binding core [18]
and T-cell receptor (TCR) ligand [19]. As expected, there were
major differences in the fractions of variant nonamer sequences of
the proteins, with more conserved positions in Gag and Pol, and
greater diversity in Env and Nef. However, despite the differences
in the structure and function of the proteins, or the extent of their
genomic diversity, the viral proteins shared characteristic patterns
of change in the incidence of index, major, minor, and unique
nonamer motifs with increased mutation. This quantitative
characterization of the mutational changes of the clade B
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proteome provides data that are applicable to the design of
vaccines and therapeutics that are least impacted by the diversity
of the viral proteins. HIV-infected individuals, ‘‘elite controllers’’,
who maintain low levels of plasma virus [20–22], as well as animal
model experiments [23–27] suggest that vaccines that generate
CD8+ T cells, even against only a few epitopes, can result in a
long-term control of virus proliferation. We suggest that an
effective immune response to HIV-1 in humans might be possible
with a vaccine comprised solely of the limited set of highly
conserved protein sequences, as described herein, that may
provide memory responses not compromised by immune escape
or the presence of competing altered peptide ligands.
Materials and Methods
Data Preparation, Selection and Alignment of HIV-1
Clade B Proteome
HIV-1 protein sequence records were retrieved from the NCBI
Entrez Protein Database [28] in August 2008 by searching the
NCBI taxonomy browser for HIV-1 (Taxonomy ID 11676). HIV-
1 clade B records were extracted from the collected data by use of
BLAST [29–32] searches (version 2.2.18; parameters: low
complexity filter – off, expect –10, descriptions and alignments –
100,000), using the HIV-1 clade B protein reference sequences
from the Los Alamos HIV sequence database (www.hiv.lanl.gov)
as queries (Table S2). Cutoff for the classification of each clade B
protein was determined by manual inspection of the BLAST
output. Possible misclassification of non-clade B HIV-1 sequences
as clade B was not apparent as the patterns of motif change were
similar for each protein, particularly for Gag, Pol, and Env
proteins that form the major basis of phylogenetic relationships
[33,34]. Additonal phylogenetic study for classification of the
sequences as clade B was not practical given the high viral
diversity, large number of sequences analysed, and the difficulty/
subjectivity in the interpretation of the phylogenetic tree due to
likely low bootstrap values. Duplicate sequences of each protein
were removed to minimize bias that may result from collection of
redundant protein sequences derived from identical HIV-1
isolates. Highly similar sequences were retained because arbitrary
removal of such sequences would introduce additional bias.
Further selection of one sequence per subject was deemed
unnecessary as it would not give a true representation of the
HIV-1 viral diversity as a complex quasispecies of genetically
related but distinct sequences in individual subjects. Thus, all non-
redundant sequences, both full-length and partial, were aligned
and analyzed. Partial sequences were included in the alignment
because they provided additional data for the study of diversity.
Multiple sequence alignment was difficult for some of the proteins
because of the large number of diverse and partial sequences, and
thus different approaches were explored. Sequence alignments of
Vif, Vpr and Vpu were performed with PROMALS3D [35]. The
large sequence datasets of Gag, Pol, Tat, Rev, Env, and Nef were
first split into smaller and more manageable groups (about 200–
500 sequences per group). These smaller groups were aligned by
use of PROMALS3D or CLUSTAL W [35,36] and refined by use
of RASCAL [37]. They were then merged into full protein
multiple sequence alignment, with conserved sites as anchors to
facilitate reliable alignment of the highly diverse positions (Figure
S1). All multiple sequence alignments were manually inspected
and corrected for misalignments. Variation in the number of
collected sequences between adjacent positions of the alignment
resulted from the inclusion of partial sequences. Alignment
positions with high fractions, 95% or more, of gaps (insertions or
deletions) were removed in order to minimize alignment errors.
Because of its great diversity, only 9,661 of the 29,211 extracted
Env protein sequences were successfully aligned and analyzed.
The selection of these Env sequences was semi-selective, however,
the large number of sequences aligned and analyzed help to
reduce sampling bias.
A caveat is the unknown history of the many recorded viral
sequences; for example, the source of the virus, infection history,
possible treatment, or details of cultivation. In addition, the quality
of the sequences from the database is also unproven. Nevertheless,
it is unlikely that analysis of another population of HIV-1 would
differ significantly from the data herein. This assertion is supported
by the sequences of individual infectious clade B viruses, HXB2
[38] and C1P [39], that have nonamer position patterns of
conservation and variability consistent to those of the historically
recorded viruses.
Nonamer Sequence Analysis Approach
HIV-1 clade B sequence alignment diversity was based on a
sliding window approach of size nine, overlapping eight amino
acids (1–9, 2–10, 3–11, etc.) that captured the entire nonamer
repertoire of the proteome [40,41]. Nonamer sequences represent
the possible core HLA and TCR binding domains, and provide a
defined examination of the protein diversity in relation to cellular
immunity. It can be assumed that each nonamer is a potential T-
cell epitope because of the large array of HLAs with different
binding specificities in the human population (HLA Informatics
Group [http://www.anthonynolan.org.uk/HIG]) and given that
an average of 0.1–5% of overlapping nonamers spanning a protein
will bind to a particular HLA molecule [42]. Moreover, in this
context, the potential immune relevance of a mutation is greatly
Figure 1. Definitions of HIV-1 clade B nonamer sequence
motifs. The different sequence motifs of the aligned HIV-1 clade B
isolates were identified as shown with 20 sequences of a model
nonamer position. The ‘‘Index’’ nonamer is the most prevalent
sequence, present in 8 of the 20 isolates. The ‘‘Major’’ variant is the
most common variant of the index (5/20). ‘‘Minor’’ variants are multiple
different repeated sequences, each with incidences less than that or
occasionally equal of the major variant. ‘‘Unique’’ variants are those
represented by a single aligned sequence. ‘‘Nonatypes’’ (boxed) are the
distinct variant sequences at a given nonamer position; in this example
one of major, two of minor, and three of unique.
doi:10.1371/journal.pone.0059994.g001
HIV-1 Clade B Variant Population Characterization
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Figure 2. HIV-1 clade B proteome nonamer sequence entropy and total variants. A. Entropy (in black) and incidence of the total variants of
the index (in red) was measured for each aligned nonamer (nine amino acids) position (1–9, 2–10, etc.) of the proteins. The entropy values indicate
the level of variability at the corresponding nonamer positions, with zero representing completely conserved sites (0% total variants incidence), with
a maximum of about 9 at the extremely variant sites (,98% total variants incidence). B. Relationship of entropy and the incidence of total variants for
the proteome nonamer positions.
doi:10.1371/journal.pone.0059994.g002
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expanded whereby a single amino acid substitution affects nine
overlapping nonamers spanning a region of 17 amino acids, except
mutations occurring in the first and last eight amino acids of the
protein termini (Figure S2). These features of immune-relevant
diversity would not be captured by variability analysis of sequence
alignments with a sliding window of size one (single amino acid
approach). Further, mutational entropy is completely different
between these two approaches, with a maximum entropy of 39 for
nonamer approach versus 4.2 for single amino acid approach.
Shannon’s Nonamer Entropy and Quantitative Analyses
of Diversity Motifs
Shannon’s nonamer entropy [31,43,44] was used as a general
measure of HIV-1 protein sequence diversity. Each nonamer
position in the protein alignments was quantitatively analysed for
the incidence (% occurrence) of the different sequences present at
the position, with arbitrary sorting for equal incidences (Figure 1).
The first ranked sequence of each position was defined as the
index, while the remaining ranked sequences with at least one
amino acid difference from the index were defined as variants and
Table 1. A sample of the quantitative analysis of HIV-1 clade B Env protein diversity‘.
Aligned nonamers H(x)c Index
d Variantse Nonatypesi HXB2
j C1Pk
Positiona No.b Sequence [%] Total Majorf Minorg Uniqueh Sequence [%] Sequence [%]
[%]
& 114–122 1032 1.0 SLKPCVKLT 86 14 6 7 1 2 ......... 86 ......... 86
& 115–123 1034 1.0 LKPCVKLTP 86 14 6 7 1 2 ......... 86 ......... 86
& 116–124 1066 1.1 KPCVKLTPL 85 15 6 8 2 3 ......... 85 ......... 85
& 117–125 1517 0.8 PCVKLTPLC 89 11 4 6 1 2 ......... 89 ......... 89
& 118–126 1568 0.8 CVKLTPLCV 89 11 5 5 1 2 ......... 89 ......... 89
& 119–127 1594 1.1 VKLTPLCVT 86 14 5 7 1 2 ........S 1 ......... 86
& 120–128 2665 1.0 KLTPLCVTL 88 12 4 7 1 2 .......S. 1 ......... 88
& 121–129 2670 1.7 LTPLCVTLN 76 24 5 17 1 2 ......S.K ,1 ......... 76
& 122–130 3112 1.9 TPLCVTLNC 74 26 5 20 1 2 .....S.K. 1 ......... 74
& 123–131 3326 2.6 PLCVTLNCT 66 34 4 28 2 4 ....S.K.. 1 ........I 2
& 124–132 3368 4.1 LCVTLNCTD 44 56 13 40 3 6 ...S.K... 1 .......I. 1
+ 125–133 3673 6.2 CVTLNCTDN 12 88 10 72 6 11 ..S.K...L 1 ......I.V ,1
+ 126–134 3675 7.4 VTLNCTDNW 10 90 3 79 8 15 .S.K...LK 1 .....I.VN ,1
+ 127–135 3677 7.8 TLNCTDNWN 9 91 3 78 9 19 S.K...LK. 1 ....I.VNI 0
+ 128–136 3719 8.3 LNCTDNWNN 6 94 2 81 11 22 .K...LK.D 1 ...I.VNIT 0
+ 129–137 3725 8.3 NCTDNWNNT 6 94 2 79 12 24 K...LK.D. ,1 ..I.VNITN 0
+ 130–138 3912 8.6 CTDNWNNTG 6 94 2 79 13 25 ...LK.D.N 1 .I.VNITNT 0
+ 131–139 3917 8.7 TDNWNNTGN 5 95 2 79 14 27 ..LK.D.NT 1 I.VNITNT. 0
+ 132–140 3911 8.9 DNWNNTGNV 5 95 2 78 15 28 .LK.D.NTN ,1 .VNITNT.S 0
+ 133–141 3863 8.8 NWNNTGNVS 5 95 2 77 16 29 LK.D.NTN. ,1 VNITNT.ST 0
+ 134–142 3838 9.0 WNNTGNVSD 5 95 2 77 16 30 K.D.NTN.S ,1 NITNT.STN 0
+ 135–143 3807 9.0 NNTGNVSDS 5 95 2 76 17 31 .D.NTN.S. 1 ITNT.STNP 0
+ 136–144 3747 9.0 NTGNVSDSS 5 95 2 76 18 32 D.NTN.S.G 1 TNT.STNPT 0
+ 137–145 3701 9.1 TGNVSDSSW 5 95 2 75 18 32 .NTN.S.GR 1 NT.STNPTS 0
+ 138–146 3473 8.9 GNVSDSSWK 4 96 1 76 19 34 NTN.S.GRM 1 T.STNPTSS 0
+ 139–147 3090 9.2 TSVNSNSSG 2 98 1 78 19 35 .NSS.GRMI 1 N.T.PT..W 0
‘All percentages are shown to the nearest whole number.
aAmino acid number at the start and end of the nonamer position in the protein alignment. The symbols & and+denote the mixed-variable and highly diverse nonamer
positions, respectively (see Figure 3 for definitions).
bTotal number of protein sequences analysed at the respective nonamer position; the differences between nonamer positions was due to the inclusion of both partial
and full-length sequences in the alignments.
cShannon nonamer entropy (H(x); see Figure 2 for details).
dThe index nonamer is the most prevalent sequence at the given aligned nonamer position.
eVariants differ by one or more amino acids from the index sequence.
fThe major variant is the most common variant sequence at the position.
gMinor variants are multiple different repeated sequences, each occurring more than once and with an incidence less than or occasionally equal to the major.
hUnique variants are those that occur only once in the alignment.
iNonatypes are the distinct sequences among the variants.
jHXB2 nonamer sequence and its incidence at the given nonamer position; amino acids identical to the index are denoted as ‘‘.’’.
kC1P nonamer sequence and its incidence at the given nonamer position; amino acids identical to the index are denoted as ‘‘.’’. HXB2 and C1P nonamers not found at
the aligned nonamer position are indicated with 0% incidence.
doi:10.1371/journal.pone.0059994.t001
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organized as three motifs: (1) ‘‘major’’ variant, the most prevalent
individual variant of the index; (2) ‘‘minor’’ variants, multiple
different sequences, each present in two or more of the aligned
viral sequences, and each with an incidence less than or equal
(occasionally) to that of the major variant; and (3) ‘‘unique’’
variants, each unique to a single viral isolate. The combined
incidence of the major, minor and unique variants at a nonamer
position was inversely related to the corresponding incidence of
the index sequence and represented the total variant population at
the position. The incidence of distinct variant nonamer sequences
at a given nonamer position (nonatypes) was also determined.
Further, the correspondence of the index sequences to the
sequences of the original clade B isolate, HXB2 [38] and an
arbitrarily selected recent strain, C1P [39] was evaluated. HXB2 is
considered the clade B prototype sequence [45], while C1P is an
infectious virus cloned full-length from residual viral RNAs
recovered from the plasma of a HAART-treated patient and
sequenced by modern methodologies.
Variant nonamers that contained gaps (-) or any one of the
unresolved characters, including B (asparagine or aspartic acid), J
(leucine or Isoleucine), X (unspecified or unknown amino acid),
and Z (glutamine or glutamic acid) were excluded from the
quantification. All data analyses were performed with the 2,874
aligned nonamer positions of the proteome that had more than
100 sequences (out of 3,133 total aligned proteome nonamer
positions). However, data for positions with less than 100
sequences are shown in some figures and tables to maintain the
protein sequence structure.
Results
Shannon Entropy Overview of HIV-1 Clade B Proteome
Sequence Diversity
Shannon entropy [31,43,44] of the aligned nonamer positions
was used as a measure of overall sequence diversity of the HIV-1
clade B proteome (Figure 2A). The remarkable complexity of the
viral protein sequence structure was evident from the extensive
presence of high entropy nonamer positions, with a large fraction
of variant sequences in each of the HIV-1 proteins, including Gag
and Pol, the most conserved. The maximum evolutionary entropy
(9.2) of HIV-1 nonamer sequences far exceeded that of ,6 for
avian influenza [32], ,4 for dengue [31], and ,2 for West Nile
virus [30]. Each of the HIV-1 proteins was found to contain
positions with greater than 50% variant sequences, and some with
variants as high as 98% of the aligned nonamer sequences. A
severe discordance in the relationship between entropy and the
incidence of variants of the nonamer positions was also evident
(Figure 2B). While high entropy is a general indication of high
diversity, several positions of lower entropy (,2.0) contained high
incidences of variants, some comparable to those of higher entropy
regions (.4.0). In general, only positions with variants incidence of
less than 20% had a relatively linear relationship with entropy. In
contrast, positions with more than 20% variants displayed a wide
range and non-linear rise in entropy that increased greatly at
positions with an incidence of variants $80%. The wide range of
entropy can be attributed to the composition and incidence of the
variant motifs that comprised of many different sequences.
Dissecting HIV-1 Clade B Proteome Sequence Diversity:
Scope of the Analysis
Dissecting protein sequence diversity of HIV-1 clade B included
quantitative analyses of diversity motifs of each of the 2,874
aligned nonamer positions of the proteome (Table S3). An
example of this data is shown with 27 aligned overlapping
nonamer positions of Env 114–148 (Table 1). Each of the 27
aligned nonamer positions contained about 1,000 to 3,900
sequences. The first five positions (Env 114–122 to 118–126)
were relatively conserved with entropies of about 1.0, and index
nonamers with incidences of 85% to 89%. These conserved
sequences were identical to the corresponding sequences of the
HXB2 and C1P. The remaining small fraction (11 to 15%) of the
aligned sequences at these conserved positions were variants of the
index nonamers and represented by about equal fractions of the
major and minor variants (5–7%), and a minimal fraction, ,1 to
,2%, of unique sequences. The incidence of the different variant
nonamer sequenes (nonatypes) at these positions was about 2%,
represented by the single major variant, different minor variants,
and unique variants. In contrast, the remaining nonamer
positions, Env 119–127 to 140–148, included positions of high
diversity, with entropy as high as about 9.2, as few as 2% index
sequences, 98% as variants of the index, and nonatypes as high as
36%, based almost totally on different minor and unique variants.
As an indication of the high variability of these positions in the
HIV-1 population, none of the approximately 2,000 to 4,000
Figure 3. Distribution of conservation level of nonamer
positions. The nonamer positions of the proteome and the individual
proteins were defined as highly conserved (black, index incidence
$90%), mixed-variable (white, index incidence ,90% & .20%), and
highly diverse (grey, index incidence#20%). Highly conserved positions
were only 9% of total proteome nonamer positions, ranging from 0%
for Vpr and Tat, to 19% for Pol. Highly diverse positions comprised 14%
of the proteome, ranging from 1% Pol to 27% Env and Nef, each. Mixed-
variable positions comprised 77% of the proteome, ranging from 69%
Env to 88% Vpr.
doi:10.1371/journal.pone.0059994.g003
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Figure 4. Dynamics of diversity motifs of HIV-1 clade B proteome. A. Motif incidence in relation to total variants incidence: index sequence
(orange), total variants (black), major variant (blue), minor variants (pink), unique variants (green), and nonatypes (yellow). B. Violin plot of the
frequency distribution of the indicated proteome sequence motifs. The width of the plot (x-axis) represents the frequency distribution of a given
incidence of the indicated motif. ‘‘x’’ represents the arithmetic mean incidence value.
doi:10.1371/journal.pone.0059994.g004
HIV-1 Clade B Variant Population Characterization
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sequences of the aligned population contained nonamers that were
identical to those of C1P, and only a small fraction (1% or less)
corresponded to HXB2 nonamers.
Distribution of Conserved and Variable Nonamer
Positions in HIV-1 Clade B Proteome
Nearly all nonamer positions of the aligned viral proteins
contained variants with one or more mutations. Only two Pol
positions with more than 100 sequences in the alignment (Pol 956–
964, 957–965) were evolutionarily completely conserved among
the recorded sequences that were analyzed in this study. Highly
conserved positions with index sequences in 90% or more of the
aligned viruses represented only 9% of the proteome, mostly in
Pol, Gag, and even Env (Figure 3). The remaining small fraction of
variant nonamers, 10% or less, of these highly conserved positions
generally contained one amino acid mismatch to the index
(median average; data not shown). Highly diverse positions, with
80% or more total variants, represented 14% of the proteome and
23 to 27% of the Env, Nef, Vpu and Rev sequences. The variant
sequences of these highly diverse positions differed greatly from
the index sequences, many with multiple amino acid mismatches
(median average of 3), contributed largely by the unique variants.
Overall, a large fraction (91%) of the proteome nonamer positions
contained more than 10% variants of the index sequence (i.e.
mixed-variable and highly diverse nonamer positions).
Dynamics of Variant Motifs with Increased Mutation
A singular finding was the distinctive dynamics of the individual
variant motifs of the HIV-1 clade B proteome in relation to
increased mutations (Figure 4A). The extreme range in the
conservation decrease represented by incidences of index sequenc-
es, 100% to 2%, was inversely matched by the increase of total
variants incidences, 0% to 98%. Although these inversely related
incidences of the index and total variants appear to be in a
continuum, drawn as a line (Figure 4A), the data depicted were the
actual values of the 2,874 nonamer positions examined. The three
variant motifs, each exhibited a characteristic distribution of
incidence change with increased total variants. The major variant
had a distinctive pyramidal incidence pattern based on the fact
that, by definition, the major variant could not exceed the index
sequence. Thus, at nonamer positions with greater than 50% total
Figure 5. Dynamics of diversity motifs of HIV-1 clade B proteins. The color key for each sequence motif is described in Figure 4.
doi:10.1371/journal.pone.0059994.g005
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variants, there was a corresponding reduced incidence of both the
index sequence and the major variant. However, although the
mean incidence of the major variant was only about 10%, there
were many positions with over 50% total variants that contained
almost equal incidence of the index and major variant. It is
apparent that index, antigen epitopes of highly diverse proteomic
positions have little quantitative dominance as an immune target
over the major variant. The minor variants, each with individual
incidence less than or occasionally equal to that of the major
variant, were collectively the predominant variant motif for
majority of positions, particularly those with greater than 50%
total variants. It is evident that the minor variants are a highly
dynamic population resulting from fitness selection support in the
continued mutation of the index sequences and major variants.
The multiple different sequences of the minor variants present
additional great variety of potential epitope sequences as immune
escape variants or altered peptide ligands. The remaining
population of variant nonamer sequences comprised of unique
variants, each representing a single viral genotype within the
recorded population. Unique variants were distinctive for their
presence at almost every nonamer position, including the highly
conserved, but with low incidences (average of 3%), despite the
increase of other variant sequences. Notably, at positions of greater
than about 60% total variants, the incidences of unique variants
for some positions were dramatically increased in each of the
proteins, particularly in Nef with a maximum incidence of 53%.
The increased observation of unique sequences represented
positions of hyper-variability, with index incidence of less than
or equal to 10% and the remaining 90% or more variants as
mostly different minor and unique nonamer sequences. The
presence of these unique variants in every protein and at nearly all
nonamer positions (Table S3), even those highly conserved,
indicates that they are not artifacts of sequencing or result of
truncated partial sequences (e.g. due to premature stop codon).
Nonatypes, a measure of distinct variant sequences (Figure 4A),
comprised a large fraction (up to 68%) of the highly diverse
positions, composed largely of different minor and unique variants.
The incidence distributions of the index and variant motifs for
the proteome are depicted by use of violin plots (Figure 4B).
Overall, the index nonamer was the principle motif, but with a
mean incidence of only about 52%. The predominant mutation of
the index was the minor variant motif, with an incidence
distribution inversely related to that of the index. The majority
of the major and unique variants were of low incidence, as also
shown in Figure 4A, but with a fraction of high incidence unique
variants, particularly at positions of $80% total variants
incidences (i.e. highly diverse positions). The nonatypes, composed
of the single major variant, the different minor variants, and each
of the singular unique variants at a nonamer position, were also
chiefly of low incidence, except at highly diverse positions due to
the great increase in unique variants incidences. The increased
incidence of different variants at highly diverse positions provides
an extreme repertoire of possible immune escape variants for a
quasispecies population.
An additional salient finding was that the dynamics in the
changes of the incidence patterns of the variant motifs were
repeated for each of the individual proteins, as most evident with
the large number of nonamer positions of Gag, Pol, Env and Nef
(Figure 5). The only distinct differences between the individual
proteins were the fraction of nonamer positions with low
incidences of variants (Gag and Pol), compared to those with
high incidences of variants (Env and Nef) (Figure 6). Thus, despite
the differences in the structures and functions of the proteins, the
motifs and incidences of the variants of the index sequences were
basically the same for each protein, with similar dynamics in the
patterns of change with increased mutation.
Correspondence of the Index Sequences to those of
HXB2 and C1P Proteins
The correspondence of HIV-1 clade B index nonamer
sequences herein defined, concatenated as full-length proteins,
was compared to Nef (Figure 7) and the other proteins (Figure S3)
of the individual HXB2 and C1P viruses. There was a high single
amino acid identity (.82%) between the historical index and the
individual sequences of these viruses (Table S4A), with differences
that included a small fraction of indels (insertions/deletions),
besides mutations (Figure 7). In contrast, the nonamer sequence
identity was much less than that of single amino acids, with only
61% of the HXB2 and 49% of the C1P nonamers identical to the
index sequences (Table S4B). As expected, the match between the
index and the individual HXB2 and C1P sequences occurred
Figure 6. Frequency distribution violin plots of the diversity
motifs incidences of HIV-1 clade B proteins. The legend for the
violin plot is described in Figure 4.
doi:10.1371/journal.pone.0059994.g006
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mainly at the highly conserved nonamer positions, and almost
none at the highly diverse positions (Table S3), highlighting the
consistency of sequence changes in the viral population. Based on
this, approximately half of the overlapping nonamer sequences of
a given HIV-1 strain can be expected to differ from the historical
index sequences of this study.
Index Switching
Index switching, another relevant finding, results from similar
incidences of the index sequences and major variants at some
mixed-variable and several highly diverse nonamer positions
where the incidences of the major variants (average of 8%) were
almost indistinguishable from the index sequences (average 12%).
Consequently, there were a significant number of nonamer
positions in the proteome where fitness increase of one or more
amino acid mutations were sufficient to change the incidence rank
of a given variant nonatype as the index, alternative to the
expected index sequence based on the preceding position
(Figure 8). Index-switching positions were readily revealed by
amino acid mutations that did not follow the consecutive
concatenation of the index sequences, as shown by the red labeled
residues in Figures 7 and S3. Index switching may also occur with
the other variant motifs and likely represents a subset of a larger
phenomenon, motif switching that may be common in a
quasispecies population, where the members of the motifs
dynamically swap ranking as mutation accumulates. This is likely
particularly so at the hyper-variable nonamer positions where the
difference in the incidences of the different nonatypes is almost
negligible.
Discussion
This study has elucidated the HIV-1 variant nonamer sequence
structure and incidence with increased mutation of the clade B
virus proteome. The virus samples, collected over at least 26 years
(1983 to 2008, based on records with available isolation date),
likely included many differences in mode of HIV transmission,
stage of infection, treatment, co-infection, etc. The results thus
provide a compendium of the possible spectrum of sequence
variants of HIV-1 under many different conditions and a model of
the collective evolution of multiple HIV-1 populations. It was
apparent that virtually all nonamer positions were capable of
generating multiple variants of index sequences for the cooperative
fitness of protein structure; only two Pol positions were completely
conserved. The remarkable plasticity of the virus was demonstrat-
ed both by incidences of the three variant motifs at the different
nonamer positions, and by the presence of numerous variant
nonatypes (distinct sequences), especially at the highly diverse
positions. Such regions of high diversity were present in each
protein, Gag and Pol included, but most commonly in Rev, Vpu,
Env, and Nef, where 23 to 27% of the aligned nonamer positions
contained 80% or more of sequences that were variants of the
index sequence. The incidence of nonatype sequences at the
highly diverse positions was remarkable; for example, about 70%
in Nef. Importantly, the reliability of this collective evolutionary
diversity was supported by the consistency with the individual
patterns of mutational change of HXB2 and C1P viruses.
Despite the many differences in structure and function of the
HIV-1 proteins, the change of incidence of the major, minor and
unique variants with increased sequence change was essentially the
same for each protein, differing only in the relative fractions of
conserved and diverse sequences. An interpretation of these data is
Figure 7. Comparison of HIV-1 clade B Nef concatenated index sequence with the HXB2 and C1P sequences. The numbers before and
after the concatenated index sequence represent amino acid positions of the comparison; the comparison is shown in blocks of 60 amino acids.
Identity of the index amino acids with those of HXB2 (green) and/or C1P (blue) is represented by ‘‘.’’; those that differ are shown by the respective
amino acid. Amino acid mutations of the aligned viruses that did not follow the concatenation of the index are shown in red. The corresponding
amino acids of HXB2 and C1P sequences are also shown at these positions, without representing identical residues by ‘‘.’’. The green dashes represent
amino acid deletions in HXB2.
doi:10.1371/journal.pone.0059994.g007
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that the three variant motifs represent inherent patterns in the
organization of a vast number of variable protein sequences that
facilitate HIV-1 fitness-selection. By definition, as the fraction of
total variants of the nonamer positions increased, the minor
variants became the predominant form, particularly as they
replaced both the index and corresponding major variant at
positions with more than 50% total variants. The large fractions of
nonatypes at highly diverse positions is in keeping with the
quasispecies model, that progeny viruses contain virtually any
sequence change consistent with the cooperative fitness of protein
sequences [2]. This pattern of sequence change was hypothesized
by Eigen [46] to have resulted from a combination of Darwin’s
selective evolution of the dominant replicator and the presence of
a ‘‘clan’’ of variant molecules that also have maximum reproduc-
tive fitness. The extreme sequence plasticity could provide a
spectrum of viral variants that allow the virus population to
efficiently exploit changes in selection pressure and facilitate the
long-term evolutionary stability and versatility of the virus [46].
The intense repertoire of variants in the mixed variable and
highly diverse regions of the virus proteome likely supports a
combination of mechanisms for loss of host immune control of the
virus. In addition to escape from T cell immunity, the multitude of
mutated sequences likely contribute to the general collapse of the
early immunity to the virus by altered peptide ligand inhibition of
T-cell responses and T-cell exhaustion [47–56]. Index switching
may be an important mechanism that facilitates this loss of
immune control. A small incidence increase of a particular amino
acid mutation in the mixed-variable and the highly diverse
positions can result in a variant nonatype replacing the prevalent,
index sequence of a quasispecies population.
Several methodologies for vaccine development that were
designed to overcome HIV-1 sequence diversity have been
reported, the majority as strategies based upon the use of
centralized sequences to limit the differences between viral strains
and the vaccine [15]. The design of these vaccines has generally
been based on phylogenetic relationship or the consensus, most
common sequence, of the viral population [57–61]. However, a
limitation of these approaches as a vaccine strategy is that, as
shown herein, the centralized or consensus sequence is not an
indicator of conservation; the average incidence of the prevalent,
index sequence was about 50%, and at the highly diverse positions
was as low as 2%. A recent modification of the centralized
approach was to prepare sets of ‘mosaic’ proteins, assembled from
fragments of natural sequences that are compressed into a small
number of native-like proteins [62–64]. However, the full-length
mosaic vaccines do not overcome the low incidence (average 12%)
of the index sequences at the highly diverse positions and have the
possibility of unnatural nonamer sequences as epitopes at the
Figure 8. Index switching. A. Gag protein alignment region of amino
acid (aa) positions 310 to 326 is shown for the first and last five
sequences of the aligned viruses. The aa position 318 (coloured) is
involved in index switching and includes two aa, the prevalent E
observed in 59% of the sequences, with its variant D in 41%. B. The nine
aligned overlapping nonamer positions (310–318, 311–319, etc.)
represent the sliding windows of the alignment region in A. Each
nonamer position is shown with the index sequence, two of the variant
nonatype sequences and the total number of remaining variant
nonatypes of incidence equal or below 10%. The first nonamer position,
310 to 318, is shown with the index sequence (41%) containing aa E at
the 9th position. The major variant (38%) contains the variable aa D at
the corresponding position. A minor variant (11%) has a mutation at aa
position 7 relative to the index. A total of 37 nonatypes had individual
incidences less or equal to 10%. The dominance of aa E in the index is
maintained for the next few nonamer positions. At position 314 to 322,
index switching is observed, where the sequence with aa D is now the
index (41%) and the one with E is the major variant (35%). This
relationship continued till position 316–324, with reversal of sequence
ranks to the original state at position 317–325, where the sequence
with aa E is the index. At an index switching position, the index is
alternative to that expected, relative to the preceding position. C.
Concatenated index, formed by linking the overlapping index
sequences of the nine nonamer positions. At position 318 (coloured),
the aa D, which did not follow the concatenation of the index is shown
below the sequence.
doi:10.1371/journal.pone.0059994.g008
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junctions of the mosaic fragment. A reported alternative was the
use of concatenated mosaic sequences selected from the conserved
regions of Gag, Pol and Env [64]; however these also contained
highly diverse sequences, including a sequence of Pol that matched
a minor variant of incidence 3% in our dataset. Further, these
mosaic constructs are also subject to unnatural junctional epitopes.
Given that all nonamer positions are capable of generating
variants, barring the two completely conserved Pol positions, our
rationale for a new vaccine strategy is one based on the selection of
peptide sequences conserved in over 90% of the recorded virus
population as a means for establishing selective T-cell based
immunity. The goal is the selective development of immune
responses that are restricted to highly conserved sequences, with a
greatly reduced incidence of mutations that could function as
altered peptide ligands. These conserved T-cell epitopes would not
be subject to competition in TCR activation by a large or even
greater fraction of variant sequences that could function in
promiscuous HLA binding but act as antagonists to the TCR
receptor. The importance of T-cell responses in the control of
HIV-1 infection has been revealed by the findings of the role of T-
cells in the reduced viremia of elite controllers [20–22]. In
addition, rhesus macaque animal model experiments [23–27]
suggested that CD8+ T cells, even against only a few epitopes,
have the potential of limiting virus replication following virus
infection and result in long-term immune control under conditions
that limit HIV-1 immune escape. The immunity provided by
peptide-based vaccines composed solely of the limited set of highly
conserved index sequences, many of which are immunogenic as
observed by matches to reported T-cell epitopes (data not shown),
may be considered a possible strategy for the development of an
HIV-1 vaccine.
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Figure S1 Sample alignments showing the anchor regions of
relatively conserved amino acids (boxed in red) that facilitated
reliable alignment. The numbers represent the amino acid
positions of the protein alignment.
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Figure S2 The effect of mutation on overlapping nonamer
sequences. A. The numbers represent amino acids of overlapping
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from C to P at position 9, will affect nine nonamers spanning 17
amino acids (boxed in red).
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Figure S3 Comparison of concatenated index sequence of each
HIV-1 clade B protein with the corresponding proteins of HXB2
(green) and C1P (blue) sequences. The numbers before and after
the concatenated index sequence represent amino acid positions of
the comparison; the comparison is shown in blocks of 60 amino
acids. Identical amino acids between the comparisons are
represented by ‘‘.’’; those that differ are shown by the respective
amino acids. Amino acid mutations of the aligned viruses that did
not follow the concatenation of the index are shown in red. The
corresponding amino acids of HXB2 and C1P sequences are also
shown at these positions, but without representing identical amino
acids by ‘‘.’’. The green and blue dashes represent amino acid
deletions in HXB2 and C1P, respectively.
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